- Author:
Chong-Yang DING
1
;
Hong-Yu LIU
2
;
Zhe GUO
1
;
Tian-Nu LI
3
Author Information
- Publication Type:Journal Article
- From: Journal of Experimental Hematology 2016;24(6):1782-1786
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the PET-CT manifestation and clinical features of patients with Waldenstrom macroglobulinemia(WM) .
METHODSThe clinical features, laboratorial examination results and PET-CT manifestation of 12 patients with WM were analyzed retrospectively.
RESULTSThe average age of 12 patients with WM was 63.5 years old, the most common incipient symptoms were fatigue and hyperviscosity syndrome. The median SUVof bone marrow was 4.9 (range of 2.1 to 21.9), with diffusely increasedF-FDG uptake in all the patients. In 6 patients, the median SUVof splenomegaly and lymphadenectasis was 3.2 (range of 2.3 to 5.2) and 5.2 (range of 3.6 to 11.2), respectively. The SUVof bone marrow, splenomegaly and lymphadenectasis did not related with white blood cell count, hemoglobin level, blood platelet count, β2- microglobulin level and serum monoclonal IgM of such patients, respectively (both P>0.5). In univariate analysis, serum monoclonal IgM and the SUVof lymphadenectasis were found to be the prognostic factors (both P<0.5).
CONCLUSIONTheF-FDG PET-CT feature of Waldenstrom macroglobulinemia has some characteristics which are helpful for setting up the clinical therapeutic schedule.